Valion Bio, Inc. Share Price
NASDAQ: VBIO$0.57
+$0.57 (--%) Last updated on 18 Nov, 2026 | 00:35 ISTValion Bio, Inc. Stock Performance
Valion Bio, Inc. Share Price Chart
$0.53$0.58
L
H
Valion Bio, Inc. Quarterly Profit & Loss
All figures in USD
About Valion Bio, Inc.
Valion Bio Inc is a late-stage biopharmaceutical company developing biologics that activate innate immune pathways for cytoprotection and immune modulation. Its main candidate, Entolimod, is a TLR5 agonist and also advances Entolasta, a next-generation TLR5 agonist, and targets the neutropenia oncology supportive care market.
Valion Bio, Inc. Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Nov 2026 | $0.54 | $0.56 | +6.00% |
Oct 2026 | $2.54 | $0.53 | -80.96% |
Sep 2026 | $3.44 | $2.80 | +2,176.42% |
Aug 2026 | $0.29 | $0.12 | -59.67% |
Jul 2026 | $0.50 | $0.30 | -40.55% |
Jun 2026 | $0.72 | $0.51 | -31.14% |
May 2026 | $0.92 | $0.74 | -20.06% |
Apr 2026 | $1.19 | $0.93 | N/A |